NEWS
- siRNA Therapies for Alzheimer's Disease
- Dual-Payload ADCs: A Revolutionary Leap in Targeted Cancer Therapy
- Top Blockbuster Drugs to Watch for in 2025
- Lung Cancer Therapies: FDA Approvals in the First Half of 2025
- 2025 ADA Highlights: A New Era for GLP-1 Therapies in Obesity and Diabetes
- HZ-PEG-HZ (1K) Successfully Completed The FDA DMF Filing
- Trodelvy: Breast Cancer Breakthrough & Beyond (Trop-2 ADC)
- Bispecific Antibodies: Approved Therapies & Emerging Pipeline Drugs
- Three ADCs Expected To Be Approved In 2024-2025
- BCMA/CD3 Bispecific Antibodies for Multiple Myeloma (MM)